CYP2B6 c.*522A>G

Variant ID: 19-41523254-A-G

NM_000767.4(CYP2B6):c.*522A>G

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs7260525
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Drug metabolism and transport gene polymorphisms and efavirenz adverse effects in Brazilian HIV-positive individuals.

The Journal Of Antimicrobial Chemotherapy
de Almeida, Tailah Bernardo TB; de Azevedo, Marcelo Costa Velho Mendes MCVM; Pinto, Jorge Francisco da Cunha JFDC; Ferry, Fernando Rafael de Almeida FRA; da Silva, Guilherme Almeida Rosa GAR; de Castro, Izana Junqueira IJ; Baker, Paxton P; Tanuri, Amilcar A; Haas, David W DW; Cardoso, Cynthia C CC
Publication Date: 2018-09-01

Variant appearance in text: rs7260525
PubMed Link: 29868865
Variant Present in the following documents:
  • Main text
View BVdb publication page



Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.

Clinical Pharmacology And Therapeutics
Burgess, Kimberly S KS; Ipe, Joseph J; Swart, Marelize M; Metzger, Ingrid F IF; Lu, Jessica J; Gufford, Brandon T BT; Thong, Nancy N; Desta, Zeruesenay Z; Gaedigk, Roger R; Pearce, Robin E RE; Gaedigk, Andrea A; Liu, Yunlong Y; Skaar, Todd C TC
Publication Date: 2018-07

Variant appearance in text: rs7260525
PubMed Link: 28960269
Variant Present in the following documents:
  • Main text
View BVdb publication page